Award
NIH Reporter #1R41AR084935-01
Development of a Novel Therapeutic Agent for Skin Fibrosis
Recipient
Not Specified
Award Amount
$306,518.00
Ceiling
$306,518.00
Awarded
September 20, 2024
Identifier
1R41AR084935-01
Award for developing a novel antifibrotic therapeutic agent for skin fibrosis, funded by NIAMS with $306,518 for FY2024, spanning 2024-2026.
Description
The project involves developing a peptide M10 as an antifibrotic therapeutic agent for skin fibrosis associated with scleroderma. It includes determining antifibrotic activity in primary skin fibroblasts and defining efficacious dosing in animal models. The award is funded by NIAMS with a total cost of $306,518 for FY2024. The project duration is from September 20, 2024, to August 31, 2026. The project aims to justify further studies for FDA clearance, scaling production, and clinical trials.